Centrocytic lymphoma: a distinct clinicopathologic and immunologic entity. A multiparameter study of 18 cases at diagnosis and relapse

Am J Pathol. 1983 Nov;113(2):181-97.

Abstract

The clinical, pathologic, and immunologic aspects of malignant lymphoma of centrocytic type (ML,cc) were studied at diagnosis and often at relapse in 18 patients. The typical patient was a middle-aged or older man with adenopathy, often massive splenomegaly, hepatomegaly, marrow involvement, and, not infrequently, peripheral blood involvement. Histopathologically, ML,cc had a diffuse or vaguely nodular growth pattern with, predominantly, cells resembling centrocytes (cleaved follicular center cells) sometimes with admixed small round lymphocytes but with virtually no transformed cells. In 2 cases the neoplastic cells formed a mantle zone around reactive-appearing follicles. Cell suspensions and frozen sections revealed the monoclonal B-cell nature of all but 1 nonmarking case, and the polyclonality of the follicles in the 1 mantle zone case tested. The B cells had some, but not all, characteristics of both normal mantle and follicular center cells when eight nodes were studied with the use of a panel of monoclonal antibodies, peanut lectin, and endogenous alkaline phosphatase activity. Of 13 patients who underwent repeat biopsies, 1 developed a high grade unclassifiable B-cell lymphoma, and 6 had less marked changes. None of 7 patients tested had a change in light chain class. In conclusion, ML,cc is a distinct entity separable from other B-cell lymphomas in which either centrocytes or small round lymphocytes predominate.

MeSH terms

  • Adult
  • Aged
  • B-Lymphocytes / immunology
  • Clone Cells
  • Female
  • Humans
  • Immunoglobulin Heavy Chains
  • Immunoglobulin Light Chains
  • Liver / pathology
  • Lymph Nodes / pathology
  • Lymphoma / genetics
  • Lymphoma / immunology
  • Lymphoma / pathology*
  • Male
  • Middle Aged
  • Mitosis
  • Phenotype
  • Prognosis
  • Spleen / pathology

Substances

  • Immunoglobulin Heavy Chains
  • Immunoglobulin Light Chains